Trials / Conditions / Acute Myeloid Leukemia With Gene Mutations

Acute Myeloid Leukemia With Gene Mutations

9 registered clinical trials studyying Acute Myeloid Leukemia With Gene Mutations — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Oral Decitabine Plus Ivosidenib as First Line for Older/Unfit Adult AML Patients NCT07507760	PETHEMA Foundation	Phase 2
Recruiting	CPX-351 and Ivosidenib for the Treatment of IDH1 Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic S NCT04493164	M.D. Anderson Cancer Center	Phase 2
Unknown	Study of the Safety and Efficacy of APR-246 in Combination With Azacitidine NCT03588078	Groupe Francophone des Myelodysplasies	Phase 1 / Phase 2
Terminated	Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Pa NCT03333486	Roswell Park Cancer Institute	Phase 2
Terminated	Midostaurin and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia and FLT3 Mut NCT02634827	Mayo Clinic	Phase 2
Completed	Natural Killer Cells Before and After Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leuke NCT01904136	M.D. Anderson Cancer Center	Phase 1 / Phase 2
Completed	Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies NCT01760655	Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University	Phase 2
No Longer Available	Expanded Treatment Protocol for Adults With FLT3-ITD Mutated Relapsed or Refractory Acute Myeloid Leukemia (AM NCT03746912	Daiichi Sankyo	—
Withdrawn	Midostaurin in Treating Older Patients With Mutated Acute Myeloid Leukemia Post-Transplant NCT02723435	Stanford University	Phase 2